• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Tammy Baldwin

Marathon’s defense of pricey orphan drug getting spotlight in Congress; running a marathon is far easier, and a lot cheaper

Steve Walker    March 9, 2017 April 6, 2017    1 Comment on Marathon’s defense of pricey orphan drug getting spotlight in Congress; running a marathon is far easier, and a lot cheaper

Steve’s Take: Marathon Pharmaceuticals LLC (Northbrook IL) caught my attention last month at the inception of an outcry when the company first announced the $89,000 price tag for its newly… Read more »

Corporate, Pharmaceuticals    Al Franken, Bernie Sanders, Bloomberg, Chuck Grassley, Cory Booker, Deflazacort, Duchenne Muscular Dystrophy, Elijah Cummings, Emflaza, Fierce Pharma, Government Accountability Office, Jeffrey Aronin, Marathon Pharmaceuticals LLC, Medscape, Motley Fool, MSNBC, Orphan Drug Act, Orrin Hatch, Patty Murray, PTC Ther­a­peu­tics, Stu­art Peltz, Tammy Baldwin, The Tufts Center for the Study of Drug Development, Tom Cotton, Wanda Moebus

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Elizabeth Holmes and Mark Zuckerberg: The rise and fall of the black turtleneck, hoodie and jeans. Op Ed
  • Coffee drinkers stunned as new study suggests caffeine consumption worsens Alzheimer’ symptoms. Now what?
  • Healthcare stocks roar back after slump, while biotech IPOs continue stampede into pipeline.
  • Smartphones are revolutionizing medicine as new apps proliferate. Then there’s the Facebook lesson for and against trusting that your data...
  • Tiny Scottish biotech TauRx lobs bomb into Alzheimer’s fracas with Phase 3 success.
  • Novartis gets FDA nod for breakthrough leukemia treatment Kymriah; with a cost of $450,000, who’s going to get it?
  • CAR-T Therapy: Personalized medicine with the promise of a cure; payers will decide who gets it
  • Government to make August CSR payment to health insurers; meanwhile, CBO says Trump threat to Obamacare would send premiums 20%
  • Tiny Scottish biotech TauRx lobs bomb into Alzheimer’s fracas with Phase 3 success.
  • Breakthrough study linking menopause to increased risk of Alzheimer’s explains why far more women than men get the disease; what...
  • Alarming study concludes most new, pricey cancer drugs don’t work; why are we just hearing about this?
  • Rx Hall of Shame Update: Former Insys employee pleads guilty in US opioid drug probe; case against ex CEO Michael...
Copyright 2018
Ribosome by GalussoThemes.com
Powered by WordPress